| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 650,567 | 393,336 | 2,010,584 | 1,914,593 | | Cost of Revenue | 418,768 | 521,135 | 1,163,094 | 1,519,381 | | | Gross Profit | 231,799 | (127,799) | 847,490 | 395,212 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 161,370 | 156,394 | 180,054 | 178,892 | | Non Recurring |
-
| 5,382 |
-
|
-
| | Others | 56,451 | (333,258) | 440,889 | 53,126 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,978 | 43,683 | 226,547 | 163,194 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,656) | 1,219 | (1,565) | (301) | | Earnings Before Interest And Taxes | 11,322 | 44,902 | 224,982 | 162,893 | | Interest Expense | 36,795 | 41,511 | 35,533 | 38,991 | | Income Before Tax | (25,473) | 3,391 | 189,449 | 123,902 | | Income Tax Expense | (9,521) | 1,427 | 60,446 | 47,939 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,952) | 1,964 | 129,003 | 75,963 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (15,952) | 1,964 | 129,003 | 75,963 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,952) | $1,964 | $129,003 | $75,963 |
|
0.51% Nasdaq 
Income Statement
